Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Bibliografiska uppgifter
Huvudupphovsmän:	Sinadinos, A, Sergijenko, A, Meng, C, Gamlin, T, Hyde, S, Gill, DR, Griesenbach, U, Alton, EWFW
Materialtyp:	Conference item
Språk:	English
Publicerad:	Cell Press 2021

Liknande verk

Development of protocols for mouse GLP-toxicology studies
av: Sinadinos, A, et al.
Publicerad: (2020)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
av: Sinadinos, A, et al.
Publicerad: (2021)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
av: Sergijenko, A, et al.
Publicerad: (2021)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
av: Sergijenko, A, et al.
Publicerad: (2020)

Gene therapy for respiratory diseases; progress and a changing context
av: Alton, EWFW, et al.
Publicerad: (2020)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
av: Balázs Bender, et al.
Publicerad: (2013-09-01)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
av: Tan, T, et al.
Publicerad: (2018)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
av: Helena Lund-Palau, et al.
Publicerad: (2022-06-01)

Lung-targeting lentiviral vector for passive immunisation against influenza
av: Tan, TK, et al.
Publicerad: (2020)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
av: Gelinas, J, et al.
Publicerad: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
av: Gélinas, J, et al.
Publicerad: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
av: Conway, CC, et al.
Publicerad: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
av: Sinadinos, A, et al.
Publicerad: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
av: Ashworth, R, et al.
Publicerad: (2018)

Lentiviral Vector Bioprocessing
av: Christopher Perry, et al.
Publicerad: (2021-02-01)

Production of lentiviral vectors
av: Otto-Wilhelm Merten, et al.
Publicerad: (2016-01-01)

Advances of Lentiviral Vectors
av: Fanrong MENG, et al.
Publicerad: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
av: Munday, R, et al.
Publicerad: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
av: Munday, R, et al.
Publicerad: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
av: Antepowicz, A, et al.
Publicerad: (2021)

The very stable lentiviral vector
av: Gwendolyn K. Binder, et al.
Publicerad: (2024-03-01)

Special Issue “Lentiviral Vectors”
av: Yasuhiro Takeuchi
Publicerad: (2022-07-01)

The Inside Out of Lentiviral Vectors
av: Stéphanie Durand, et al.
Publicerad: (2011-02-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
av: Agata Antepowicz, et al.
Publicerad: (2021-08-01)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
av: Griesenbach, U, et al.
Publicerad: (2011)

Enhanced lentiviral production through rational design of mammalian host cells
av: Hyde, S, et al.
Publicerad: (2016)

Lentiviral Vectors for Ocular Gene Therapy
av: Yvan Arsenijevic, et al.
Publicerad: (2022-07-01)

Comparison of lentiviral vector titration methods
av: Debyser Zeger, et al.
Publicerad: (2006-07-01)

An Improved Protocol for the Production of Lentiviral Vectors
av: Logan Y. Brown, et al.
Publicerad: (2020-12-01)

Rev-dependent lentiviral expression vector
av: Beddall Margaret H, et al.
Publicerad: (2007-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
av: Yáñez-Muñoz, R, et al.
Publicerad: (2006)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
av: Inès Dufait, et al.
Publicerad: (2012-01-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
av: Massimo Conese, et al.
Publicerad: (2010-01-01)

Lentiviral Vector Gene Transfer to Porcine Airways
av: Patrick L Sinn, et al.
Publicerad: (2012-01-01)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
av: Munday, RJ, et al.
Publicerad: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
av: Munday, RJ, et al.
Publicerad: (2022)

Moving lentiviral-based gene therapy into a first-in-man CF trial
av: Griesenbach, D, et al.
Publicerad: (2015)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
av: Alton, E, et al.
Publicerad: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
av: Alton, E, et al.
Publicerad: (2014)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
av: Munday, RJ, et al.
Publicerad: (2022)